Medicure MCUJF
OTC MCUJF
$2.93 -0.05 (-1.68%)
At close: Oct 15, 2026 · 4:00 PM EDT

Medicure (MCUJF) Research & Development (2009 - 2026)

Updated

Medicure (MCUJF) posted Research & Development of $439,539 for the quarter ended Jun 30, 2026, down 17.8% from $534,789 a year earlier.

Analysis

Medicure (MCUJF) Research & Development (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Medicure was -$1.53 million; for the year ended Dec 31, 2025, it came in at $2.28 million, up 1.1% from the prior year.

  • Annual Research & Development shows a five-year compound annual growth rate of -1.6% (years ended Dec 2020 to Dec 2025).
  • In prior years, Medicure's Research & Development was $2.25 million in the year ended Dec 31, 2024 (+26.2%), $1.78 million in the year ended Dec 31, 2023 (-15.8%), $2.12 million in the year ended Dec 31, 2022 (+47.8%) and $1.43 million in the year ended Dec 31, 2021 (-41.8%).
  • Quarterly Research & Development has run from a low of -$825,366 in the quarter ended Dec 31, 2025 to a high of $1.04 million in the quarter ended Jun 30, 2022 over five years.
  • On a year-over-year basis, Research & Development increased in 1 of the last four quarters, with an average decline of 0.1%.
  • The strongest year-over-year quarter for Research & Development in the past five years was the quarter ended Jun 30, 2022, with growth of 81.1%; the weakest was the quarter ended Jun 30, 2023, with a decline of 52.1%.
  • According to Business Quant data, Research & Development for the three prior quarters was -$623,471 (quarter ended Mar 31, 2026), -$825,366 (quarter ended Dec 31, 2025) and -$520,997 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,158.92 Bn 1,127.51 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 624.53 Bn 543.05 Bn 17.26 Bn 3.65 Bn
3 AbbVie 511.96 Bn 485.07 Bn 12.70 Bn 2.34 Bn
4 Merck 366.03 Bn 320.41 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 297.25 Bn 261.24 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.04 Bn 234.72 Bn 12.86 Bn 4.05 Bn
7 Amgen 234.72 Bn 190.12 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 193.91 Bn 168.11 Bn 6.22 Bn 1.76 Bn
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn 2.81 Bn
10 Medicure 32.67 Mn 24.51 Mn 2.31 Mn 439,538.57
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 439,538.57
Mar 31, 2026 623,470.87
Dec 31, 2025 825,366.31
Sep 30, 2025 520,997.30
Jun 30, 2025 -534,788.96
Mar 31, 2025 397,242.39
Dec 31, 2024 -531,160.06
Sep 30, 2024 -582,777.46
Jun 30, 2024 -634,629.99
Mar 31, 2024 501,668.53
Dec 31, 2023 -517,113.01
Sep 30, 2023 378,932.68
Jun 30, 2023 497,294.25
Mar 31, 2023 -389,080.29
Dec 31, 2022 -567,997.97
Sep 30, 2022 -240,758.32
Jun 30, 2022 1.04 Mn
Mar 31, 2022 272,369.01
Sep 30, 2021 371,783.56
Jun 30, 2021 573,536.65
API Access

Medicure Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=MCUJF&period=max&api_key=YOUR_API_KEY